Breaking News

Arrowhead Pharmaceuticals Inc (ARWR)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

22.12 +0.25 +1.14%

26/04 - Closed. Currency in USD ( Disclaimer )

After Hours

21.62

-0.50

-2.26%

0:22:27 - Real-time Data

Type: Equity

Market: United States

Volume: 601,266
Bid/Ask: 21.61 / 22.46
Day's Range: 21.72 - 22.36

Arrowhead Pharmaceuticals Inc Company Profile

Get an in-depth profile of Arrowhead Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

525

Equity Type

ORD

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company’s products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.

Contact Information

Address 177 East Colorado Boulevard Suite 700
Pasadena, 91105
United States

Phone 626 304 3400

Fax 626 304 3401

Web arrowheadpharma.com

Top Executives

Name	Age	Since	Title
Douglass B. Given	71	2010	Chairman of the Board
Christopher R. Anzalone	52	2007	CEO, President & Director
Robert G. Gish	-	-	Chairman of Hepatitis B Clinical Advisory Board
William D. Waddill	65	2018	Independent Director
Michael S. Perry	64	2011	Independent Lead Director
Mauro Ferrari	64	2008	Independent Director
Carlo Ferrari	-	-	Member of Hepatitis B Clinical Advisory Board
Stephen Alister Locarnini	-	-	Member of Hepatitis B Clinical Advisory Board
Ching-Lung Lai	-	-	Member of Hepatitis B Clinical Advisory Board
Jeffrey H. Teckman	-	-	Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board
Johnson Y. N. Lau	-	-	Member of Hepatitis B Clinical Advisory Board
James K. Stoller	-	-	Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board
Rohit Loomba	-	-	Member of Alpha-1 Antitrypsin Deficiency Clinical Advisory Board
Victoria M. Vakiener	59	2022	Independent Director
Adeoye Y. Olukotun	78	2020	Independent Director
Mark M. Davis	-	-	Founder and Founder & Director of Insert Therapeutics Inc & Calando
Hongbo Lu	52	2024	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

ARWR Comments

Write your thoughts about Arrowhead Pharmaceuticals Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	3,636.84	+0.19	+0.01%
NSE All Share	98,176.76	+7.46	+0.01%
US 30	38,261.5	+175.7	+0.46%
US 500	5,099.6	+51.2	+1.01%
FTSE 100	8,139.83	+60.97	+0.75%
DAX	18,166.91	+249.63	+1.39%
South Africa Top 40	69,357.67	+920.38	+1.34%

Brent Oil	89.38	+0.37	+0.42%
Crude Oil WTI	83.66	+0.09	+0.11%
Gold	2,349.60	+7.10	+0.30%
Silver	27.380	-0.122	-0.44%
Copper	4.5800	+0.0485	+1.07%
London Cocoa	9,491.00	-126.00	-1.31%
London Wheat	183.45	+2.90	+1.61%

Nigeria 10Y	19.465	-0.068	0.00%
Nigeria 2Y	18.955	+0.014	+0.00%
U.K. 10Y	4.3690	+0.0410	+0.95%
Germany 10Y	2.5770	+0.0030	+0.12%
U.S. 10Y	4.663	-0.006	-0.13%
U.S. 5Y	4.687	-0.005	-0.11%
U.S. 2Y	4.993	-0.007	-0.13%

Access Bank	10.00	+0.00	+0.00%
Zenith Bank	32.80	-0.30	-0.91%
UBA	23.00	+0.20	+0.88%
FBN Holdings	20.35	+1.85	+10.00%
Guaranty Trust Holding	35.50	-0.45	-1.25%
Sterling Bank	4.100	+0.280	+7.33%
Dangote Cement	591.10	-65.60	-9.99%

Recent Quotes

	Name	Price	Chg.	Chg. %
	ARWR	22.12	+0.25	+1.14%

Market Movers

Name	Last	Chg. %	Vol.
UBA	23.00	+0.88%	39.21M
Access Holdings	16.60	+3.75%	28.28M
Zenith Bank	32.80	-0.91%	23.94M
Guaranty Trust Holding	35.50	-1.25%	16.55M
Nigerian Breweries	26.50	-2.90%	15.56M
Transcorp	13.950	-0.36%	14.00M
Nestle Nigeria	800.00	-3.01%	685.87K

Name	Last	Chg. %	Vol.
STANBIC IBTC Bank	49.45	+10.00%	1.12M
Nigerian Exchange	23.10	+10.00%	604.46K
Flour Mills of Nigeria	33.55	+10.00%	77.19K
FBN Holdings	20.35	+10.00%	7.74M
Skye Shelter Fund	111.45	+9.97%	0.25K
Morison Industries	4.09	+9.95%	3.68K
Livestock	1.66	+9.93%	2.45M

Name	Last	Chg. %	Vol.
ETI	23.40	-10.00%	37.83K
Airtel Africa	1,980.00	-10.00%	0.11K
Chellarams	3.69	-10.00%	0.24K
Geregu Power	900.00	-10.00%	0.78K
Sovereign Trust Insurance Plc	0.36	-10.00%	1.02M
Dangote Sugar	43.20	-10.00%	82.50K
Secure Electronic Tech	0.54	-10.00%	12.30K